Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transactions
SEC Form 4 Filing
Director Myrtle S. Potter reports the vesting and disposal of restricted stock units in Guardant Health, Inc.
Summary
- On August 15, 2024, Myrtle S. Potter, a director of Guardant Health, Inc., reported transactions involving the company's stock.
- Potter disposed of 68 shares of Common Stock at a price of $0 following the vesting of Restricted Stock Units.
- Following the transaction, Potter directly owns 13,448 shares of Common Stock and 958 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by a company director, with no inherent positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| October 15, 2022 | Initial vesting date for 25% of the restricted stock units. |
| August 15, 2024 | Date of transaction: disposal of shares upon vesting of restricted stock units. |
| August 19, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.